Evidence map›Paper›PMID 27306506›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2016

Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.

Violette Dirix, Kinda Schepers, Marguerite Massinga-Loembe, William Worodria, Robert Colebunders, Mahavir Singh, Camille Locht, Luc Kestens, Françoise Mascart, TB-IRIS study group

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 6 countries.

Violette Dirix*Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (ULB), Brussels, Belgium; †Currently, CHU Pointe-à-Pitre, Pointe-à-Pitre, Guadeloupe; ‡Laboratory of Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; §Currently, Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; ‖Département de Bacterio-virologie, Université des Sciences de la Santé, Libreville, Gabon; ¶Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; #Department of Medicine, Mulago Hospital, College of Health Sciences, Makarere University, Kampala, Uganda; **Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; ††Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium; ‡‡Currently, International Health Unit, Faculty of Medicine and Health Sciences, Gouverneur Kinsbergen Centrum, University of Antwerp, Wilkrijk, Belgium; §§Lionex Diagnostics & Therapeutics, Braunschweig, Germany; ‖‖Inserm, U1019, Lille, France; ¶¶CNRS, UMR8204, Lille, France; ##University of Lille, U1019-UMR8204-CIIL-, Center for Infection and Immunity of Lille, Lille, France; ***Institut Pasteur de Lille, Lille, France; †††Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; and ‡‡‡Immunobiology Clinic, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Kinda Schepers
Marguerite Massinga-Loembe
William Worodria
Robert Colebunders
Mahavir Singh
Camille Locht
Luc Kestens
Françoise Mascart
TB-IRIS study group
University of Antwerp · BECentre de Recherche Médicales de Lambaréné · GACentre Hospitalier Universitaire Pointe-à-Pitre · GPErasmus Hospital · BELionex (Germany) · DEMulago Hospital · UGUniversité de Lille · FRUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate whether mycobacterial antigen-induced cytokine secretions are helpful in detecting Mycobacterium tuberculosis (Mtb) infection in a cohort of HIV-infected patients living in a country with a high burden of Mtb and HIV infections, and to determine their predictive value for the development of tuberculosis (TB)-associated immune reconstitution inflammatory syndrome.

designA total of 352 HIV-infected patients (186 with active TB) were prospectively enrolled when initiating antiretroviral therapy (ART). Sequential blood samples were collected during the first 6 months of ART. Eighty-three HIV-uninfected subjects (39 with active TB) were enrolled as controls.

methodsThe concentrations of 13 cytokines were measured in supernatants from blood mononuclear cells in vitro stimulated with purified protein derivative (PPD), heparin-binding hemagglutinin (HBHA) or early secreted antigen-6 (ESAT-6) and culture filtrate protein-10 (CFP-10), and results were compared with those of tuberculin skin tests (TST).

resultsThe best detection of Mtb infection was achieved by ESAT-6/CFP-10-induced interferon-γ concentrations, but results were often negative for patients with CD4 T-cell counts <50 per cubic millimeters. Patients with active TB were identified by high ESAT-6/CFP-10-induced interleukin-6. Conversions of interferon-γ-release assays (IGRA) and TST occurred under ART, and combined TB and antiretroviral treatments of coinfected patients resulted in a decrease of ESAT-6/CFP-10-induced and an increase of HBHA-induced interferon-γ responses. No Mtb antigen-induced cytokines allowed us to predict TB-immune reconstitution inflammatory syndrome or ART-associated TB.

conclusionsIn Uganda, ESAT-6/CFP-10-IGRA is better in detecting Mtb infection than TST and, when combined with an HBHA-IGRA, could help to evaluate anti-TB treatment success.

Indexed as

CD4-Positive T-LymphocytesCytokinesHIV InfectionsHumansInterferon-gamma Release TestsLatent TuberculosisMycobacterium tuberculosisUgandaCytokines

Identifiers

PMID27306506
PMCPMC4915752
OpenAlexW2289695595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.